Ascendis Pharma A/S Noncurrent Derivative Financial Liabilities
Ascendis Pharma A/S (ASND) had Noncurrent Derivative Financial Liabilities of EUR 143.30 million as of 2023-12-31, per its 20-F filed 2025-02-12.
Financial Statements › Notes › Derivative Instruments and Hedging Activities
ifrs-full:NoncurrentDerivativeFinancialLiabilities · last filed 2025-02-12
- 2023-12-31: Noncurrent Derivative Financial Liabilities 143.30M EUR; Noncurrent Derivative Financial Liabilities as first filed 143.30M EUR.
- 2023-09-30: Noncurrent Derivative Financial Liabilities 93.35M EUR.
- 2023-06-30: Noncurrent Derivative Financial Liabilities 86.39M EUR.
- 2023-03-31: Noncurrent Derivative Financial Liabilities 116.77M EUR.
| Period end | Noncurrent Derivative Financial Liabilities | Noncurrent Derivative Financial Liabilities as first filed |
|---|---|---|
| 2023-12-31 | 143.30M EUR 20-F · filed 2025-02-12 | 143.30M EUR 20-F · filed 2024-02-07 |
| 2023-09-30 | 93.35M EUR 6-K · filed 2023-11-07 | |
| 2023-06-30 | 86.39M EUR 6-K · filed 2023-09-05 | |
| 2023-03-31 | 116.77M EUR 6-K · filed 2023-04-27 | |
| 2022-12-31 | 157.95M EUR 20-F · filed 2024-02-07 | |
| 2022-09-30 | 132.73M EUR 6-K · filed 2022-11-02 | |
| 2022-06-30 | 102.03M EUR 6-K · filed 2022-08-10 | |
| 2022-03-31 | 141.38M EUR 6-K · filed 2022-05-11 | |
| 2021-12-31 | 0.00 EUR 6-K · filed 2022-11-02 |